Logo image of ITOS

ITEOS THERAPEUTICS INC (ITOS) Stock Analyst Ratings

NASDAQ:ITOS - Nasdaq - US46565G1040 - Common Stock - Currency: USD

10.18  +0.02 (+0.2%)

After market: 10.17 -0.01 (-0.1%)

Buy % Consensus

73

ChartMill assigns a Buy % Consensus number of 73% to ITOS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 11.99. This target is 17.73% above the current price.
ITOS was analyzed by 12 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about ITOS.
In the previous month the buy percentage consensus was at a similar level.
ITOS was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
ITOS Historical Analyst RatingsITOS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -59 -53 -47 -41 -35 -29 -23 -17 -11 -5 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 10.1811.1112.2411.9912.60 - 9.14% 20.24% 17.73% 23.77%
ITOS Current Analyst RatingITOS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-05-28 Wedbush Downgrade Outperform -> Neutral
2025-05-28 Wells Fargo Downgrade Overweight -> Equal-Weight
2025-05-14 Leerink Partners Downgrade Outperform -> Market Perform
2025-05-14 Wells Fargo Maintains Overweight -> Overweight
2025-05-14 Piper Sandler Maintains Overweight -> Overweight
2025-05-14 HC Wainwright & Co. Downgrade Buy -> Neutral
2025-05-13 JP Morgan Downgrade Overweight -> Neutral
2025-04-29 Wells Fargo Maintains Overweight -> Overweight
2025-03-06 Wells Fargo Maintains Overweight -> Overweight
2025-03-06 JP Morgan Maintains Overweight -> Overweight
2025-03-06 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-19 Wells Fargo Maintains Overweight -> Overweight
2024-12-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-13 Wells Fargo Initiate Overweight
2024-08-12 JP Morgan Maintains Overweight -> Overweight
2024-05-13 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-12 JP Morgan Maintains Overweight -> Overweight
2024-03-07 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-13 JP Morgan Maintains Overweight -> Overweight
2023-10-18 Wedbush Reiterate Outperform -> Outperform
2023-08-09 HC Wainwright & Co. Maintains Buy -> Buy
2023-03-17 HC Wainwright & Co. Reiterate Buy
2023-03-16 Wedbush Maintains Outperform
2023-03-16 JP Morgan Maintains Overweight
2022-05-13 SVB Leerink Maintains Outperform
2021-12-13 HC Wainwright & Co. Maintains Buy
2021-11-12 SVB Leerink Maintains Outperform